Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension

Benoît Ranchoux, Fabrice Antigny, Catherine Rücker‐Martin, +16

Circulation

mTOR pathway activation drives lung cell senescence and emphysema

Amal Houssaïni, Marielle Breau, Kanny Kebe, +19

JCI Insight

InflammationMtor ActivationAgingLung InflammationLongevity +10

CCR2/CCR5-mediated macrophage–smooth muscle cell crosstalk in pulmonary hypertension

Shariq Abid, Élisabeth Marcos, Aurélien Parpaleix, +11

European Respiratory Journal

Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension

Amal Houssaïni, Shariq Abid, Nathalie Mouraret, +8

American Journal of Respiratory Cell and Molecular Biology

Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension

Aurélien Parpaleix, Valérie Amsellem, Amal Houssaïni, +10

European Respiratory Journal

Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression

E. Born, Larissa Lipskaia, Marielle Breau, +16

Circulation

Activation of Lung p53 by Nutlin-3a Prevents and Reverses Experimental Pulmonary Hypertension

Nathalie Mouraret, Élisabeth Marcos, Shariq Abid, +9

Circulation

CCR5 as a Treatment Target in Pulmonary Arterial Hypertension

Valérie Amsellem, Larissa Lipskaia, Shariq Abid, +15

Circulation

Osteopontin, a Key Mediator Expressed by Senescent Pulmonary Vascular Cells in Pulmonary Hypertension

Mirna Saker, Larissa Lipskaia, Élisabeth Marcos, +17

Arteriosclerosis Thrombosis and Vascular Biology

Effects of HIV Protease Inhibitors on Progression of Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension in Rats

Guillaume Gary‐Bobo, Amal Houssaïni, Valérie Amsellem, +9

Circulation